A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference

Abstract

TO THE EDITOR: Multiple myeloma (MM) is a malignant plasma cell disorder resulting in expansion of clonal plasma cells that encode for a unique monoclonal immunoglobulin (M-protein). The M-protein is derived from recombination and somatic hypermutation events occurring at both the heavy- and light-